From Louis Slesin, Microwave News:
A major review of cell phone cancer risks is at the center of an ongoing controversy over whether it is biased and should be withdrawn.
The new paper by some of the most prominent members of the RF–health community contends that epidemiological studies do not show an increased risk of brain tumors or acoustic neuroma associated with the use of mobile phones. That is, cell phones are cancer safe.
Titled “Brain and Salivary Gland Tumors and Mobile Phone Use: Evaluating the Evidence from Various Epidemiological Study Designs,” the new paper is a detailed look at the literature and includes a meta-analysis of many of the studies that have been completed over the years. The lead author is Martin Röösli of the University of Basel in Switzerland.
The paper is slated to appear in the 2019 edition of the Annual Review of Public Health, which is scheduled to be published in the spring. The paper was posted online on January 11.
Röösli has four coauthors: Maria Feychting of Sweden’s Karolinska Institute; Joachim Schüz, a senior manager at IARC in Lyon, France; Italy’s Susanna Lagorio; and the U.K.’s Minouk Schoemaker. Both Röösli and Feychting are members of ICNIRP; Feychting is its vice chair.
Four of the five, all except Röösli, worked on IARC’s Interphone project, a 13-country study of cell phones and cancer. They were part of the faction that maintained the results do not show a link.
At the close of the panel meeting, there was talk of a minority report by those who disagreed with the 2B designation. But it never happened. The Annual Review paper fills that gap, though it’s a bit late as many are now asking IARC to reclassify RF radiation as a probable human carcinogen (2A), or even as a known carcinogen (1) in light of the NTP and Ramazzini animal studies….SNIP
Also see the Microwave News companion article : Row over Cancer, Call Phone Review